Issue Date: January 2, 2017
Lygos gets funding for malonic acid
Biobased chemical start-up Lygos has raised $13 million in a first round of venture funding. Using synthetic biology methods, Lygos developed yeast strains that produce malonic acid, an intermediate used in flavors, fragrances, and pharmaceuticals that is currently made with a cyanide-based route. The company says it is producing sample quantities of bio-malonic acid. It will use the funds to scale up output to ton quantities and expand its workforce.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society